Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.85 -0.07 (-0.59%)
At close: Nov 11, 2026 · 4:00 PM EST

Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026)

Updated

Zevra Therapeutics' FCF Margin was 25.95% in Q3 2026, up 10.03 percentage points from 15.92% a year earlier but down 16.41 percentage points from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) FCF Margin (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Zevra Therapeutics' FCF Margin was 25.89% through Sep 30, 2026, up 54.59 percentage points year-over-year; for FY2025, it was -2.28%, up 292.76 percentage points from FY2024.

  • FCF Margin shows a five-year change of +12.56 percentage points (FY2020 to FY2025).
  • In earlier years, FCF Margin was -295.04% in FY2024 (-171.84 pp), -123.20% in FY2023 (+61.92 pp), -185.12% in FY2022 (-221.20 pp) and 36.08% in FY2021 (+50.92 pp).
  • Quarterly FCF Margin has moved between -490.30% (Q3 2024) and 42.36% (Q2 2026) over five years.
  • Compared with a year earlier, FCF Margin has increased for seven straight quarters, with an average year-over-year change of +202.35 percentage points over the last eight quarters.
  • The best year-over-year quarter for FCF Margin over five years was Q3 2025 (a gain of 506.22 percentage points); the worst was Q2 2022 (a drop of 454.69 percentage points).
  • Per Business Quant data, ZVRA's FCF Margin in the three quarters before Q3 2026 was 42.36% (Q2 2026), 16.86% (Q1 2026) and 16.24% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.03%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 41.97%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.51%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 52.85%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.25%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 57.81%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 28.96%
10 Zevra Therapeutics 708.52 Mn -100.24 Mn 36.01 Mn 25.95%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 25.95%
Jun 30, 2026 42.36%
Mar 31, 2026 16.86%
Dec 31, 2025 16.24%
Sep 30, 2025 15.92%
Jun 30, 2025 -14.73%
Mar 31, 2025 -40.79%
Dec 31, 2024 -135.28%
Sep 30, 2024 -490.30%
Jun 30, 2024 -429.51%
Mar 31, 2024 -471.97%
Dec 31, 2023 -125.62%
Sep 30, 2023 -165.80%
Jun 30, 2023 -103.03%
Mar 31, 2023 -128.27%
Dec 31, 2022 -222.35%
Sep 30, 2022 -230.55%
Jun 30, 2022 -316.85%
Mar 31, 2022 -90.01%
Dec 31, 2021 -33.50%
API Access

Zevra Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY